Insider Selling: Agilent Technologies (NYSE:A) Director Sells $95,974.92 in Stock

Key Points

• Agilent director Mikael Dolsten sold 634 shares for approximately $95,975, reducing his direct ownership by 11.41% to 4,924 shares.
• Agilent shares recently traded at $144.79, down 1.4%, while the company reported quarterly EPS of $1.62 and revenue of $1.88 billion, both exceeding analyst expectations.
• Wall Street maintains a “Moderate Buy” consensus, with an average price target of $170.33; institutional investors own 87.41% of the company’s stock.

Agilent Technologies, Inc. (NYSE:A - Get Free Report) Director Mikael Dolsten sold 634 shares of Agilent Technologies stock in a transaction that occurred on Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the transaction, the director directly owned 4,924 shares in the company, valued at approximately $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Agilent Technologies Stock Down 1.4%

Shares of A traded down $2.06 during trading hours on Wednesday, hitting $144.79. The stock had a trading volume of 1,843,878 shares, compared to its average volume of 2,247,818. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The firm has a 50 day simple moving average of $142.90 and a 200-day simple moving average of $128.22. Agilent Technologies, Inc. has a 1-year low of $108.35 and a 1-year high of $163.75. The firm has a market capitalization of $40.82 billion, a P/E ratio of 28.50, a price-to-earnings-growth ratio of 2.30 and a beta of 1.24.

Agilent Technologies (NYSE:A - Get Free Report) last released its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.49 by $0.13. The business had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The company's quarterly revenue was up 8.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.37 EPS. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. Sell-side analysts predict that Agilent Technologies, Inc. will post 6.2 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on A shares. Weiss Ratings reissued a "hold (c)" rating on shares of Agilent Technologies in a research report on Friday, August 28th. Sanford C. Bernstein lifted their price target on Agilent Technologies from $155.00 to $180.00 and gave the stock an "outperform" rating in a report on Thursday, August 27th. UBS Group initiated coverage on Agilent Technologies in a research report on Wednesday. They issued a "neutral" rating and a $165.00 price objective on the stock. JPMorgan Chase & Co. raised their target price on Agilent Technologies from $180.00 to $190.00 and gave the company an "overweight" rating in a research report on Thursday, August 27th. Finally, Barclays boosted their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an "overweight" rating in a report on Thursday, August 27th. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and five have issued a Hold rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $170.33.

Institutional Trading of Agilent Technologies

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. California State Teachers Retirement System boosted its holdings in Agilent Technologies by 12,343.3% in the 2nd quarter. California State Teachers Retirement System now owns 54,577,058 shares of the medical research company's stock valued at $7,249,471,000 after purchasing an additional 54,138,451 shares during the period. State Street Corp lifted its holdings in shares of Agilent Technologies by 1.9% in the 4th quarter. State Street Corp now owns 12,681,792 shares of the medical research company's stock worth $1,725,611,000 after acquiring an additional 241,029 shares during the last quarter. Wellington Management Group LLP boosted its position in Agilent Technologies by 2.7% during the second quarter. Wellington Management Group LLP now owns 7,454,686 shares of the medical research company's stock valued at $990,206,000 after buying an additional 198,253 shares during the period. Geode Capital Management LLC grew its position in Agilent Technologies by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 7,425,861 shares of the medical research company's stock worth $1,006,519,000 after acquiring an additional 25,139 shares during the last quarter. Finally, Deutsche Bank AG increased its stake in shares of Agilent Technologies by 17.1% in the second quarter. Deutsche Bank AG now owns 7,008,634 shares of the medical research company's stock worth $930,957,000 after buying an additional 1,024,516 shares during the period. 87.41% of the stock is currently owned by institutional investors.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company's offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.